Incyte Corporation (INCY) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Biotechnology industry.
Over the past 4 years, Incyte Corporation has achieved a revenue compound annual growth rate (CAGR) of 12.3%.
Historical revenue and profitability trends for Incyte Corporation
The chart above illustrates Incyte Corporation's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Incyte Corporation's business.
How efficiently Incyte Corporation converts revenue into profit
Profit margins reveal how much of each dollar of revenue Incyte Corporation retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project Incyte Corporation to continue growing earnings in the coming year. The consensus analyst rating is 3.6667 based on 27 analysts.
Based on our comprehensive analysis, Incyte Corporation (INCY) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Incyte Corporation's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Incyte Corporation stacks up against similar companies
Explore growth analysis for top stocks
Related: INCY Valuation, INCY Dividend, INCY Financial Health
Compare: INCY vs AAPL, INCY vs MSFT, INCY vs GOOGL